Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 18 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Keyword is Administration, Inhalation  [Clear All Filters]
Journal Article
Zarogoulidis, P., Hohenforst-Schmidt W., Darwiche K., Krauss L., Sparopoulou D., Sakkas L., et al. (2013).  2-diethylaminoethyl-dextran methyl methacrylate copolymer nonviral vector: still a long way toward the safety of aerosol gene therapy.. Gene Ther. 20(10), 1022-8.
Zarogoulidis, P., Kioumis I., Porpodis K., Spyratos D., Tsakiridis K., Huang H., et al. (2013).  Clinical experimentation with aerosol antibiotics: current and future methods of administration.. Drug Des Devel Ther. 7, 1115-34.
Iosifidis, E., Antachopoulos C., Ioannidou M., Mitroudi M., Sdougka M., Drossou-Agakidou V., et al. (2010).  Colistin administration to pediatric and neonatal patients.. Eur J Pediatr. 169(7), 867-74.
Zarogoulidis, P., Darwiche K., Yarmus L., Spyratos D., Secen N., Hohenforst-Schmidt W., et al. (2014).  Defense mechanisms of the respiratory system and aerosol production systems.. Med Chem. 10(2), 123-36.
Tsakalidis, C., Kourti M., Karagianni P., Rallis D., Porpodi M., & Nikolaidis N. (2011).  Early rescue administration of surfactant and nasal continuous positive airway pressure in preterm infants <32 weeks gestation.. Indian Pediatr. 48(8), 601-5.
Darwiche, K., Zarogoulidis P., Karamanos N. K., Domvri K., Chatzaki E., Constantinidis T. C., et al. (2013).  Efficacy versus safety concerns for aerosol chemotherapy in non-small-cell lung cancer: a future dilemma for micro-oncology.. Future Oncol. 9(4), 505-25.
Spyratos, D., Chloros D., Michalopoulou D., & Sichletidis L. (2016).  Estimating the extent and economic impact of under and overdiagnosis of chronic obstructive pulmonary disease in primary care.. Chron Respir Dis. 13(3), 240-6.
Zarogoulidis, P., Porpodis K., Kioumis I., Petridis D., Lampaki S., Spyratos D., et al. (2014).  Experimentation with inhaled bronchodilators and corticosteroids.. Int J Pharm. 461(1-2), 411-8.
Zarogoulidis, P., Eleftheriadou E., Sapardanis I., Zarogoulidou V., Lithoxopoulou H., Kontakiotis T., et al. (2012).  Feasibility and effectiveness of inhaled carboplatin in NSCLC patients.. Invest New Drugs. 30(4), 1628-40.
Papakonstantinou, E., Klagas I., Karakiulakis G., Tamm M., Roth M., & Stolz D. (2018).  Glucocorticoids and β-agonists regulate the pathologic metabolism of hyaluronic acid in COPD.. Pulm Pharmacol Ther. 48, 104-110.
Zarogoulidis, P., Darwiche K., Krauss L., Huang H., Zachariadis G. A., Katsavou A., et al. (2013).  Inhaled cisplatin deposition and distribution in lymph nodes in stage II lung cancer patients.. Future Oncol. 9(9), 1307-13.
Kosmidis, C., Sapalidis K., Zarogoulidis P., Sardeli C., Koulouris C., Giannakidis D., et al. (2019).  Inhaled Cisplatin for NSCLC: Facts and Results.. Int J Mol Sci. 20(8), 
Zarogoulidis, P., Kontakiotis T., & Zarogoulidis K. (2012).  Inhaled gene therapy in lung cancer: "as for the future, our task is not to foresee it, but to enable it".. Ther Deliv. 3(8), 919-21.
Pitsiou, G., Paspala A., Bagalas V., Boutou A. K., & Stanopoulos I. (2013).  Inhaled iloprost plus levosimendan to decompensate right heart failure due to chronic thromboembolic pulmonary hypertension.. Anaesth Intensive Care. 41(4), 554-6.
Zarogoulidis, P., Papanas N., Kouliatsis G., Spyratos D., Zarogoulidis K., & Maltezos E. (2011).  Inhaled insulin: too soon to be forgotten?. J Aerosol Med Pulm Drug Deliv. 24(5), 213-23.
Pitsiou, G., Zarogoulidis P., Petridis D., Kioumis I., Lampaki S., Organtzis J., et al. (2014).  Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment.. Drug Des Devel Ther. 8, 1753-63.
Porpodis, K., Papakosta D., Manika K., Kontakiotis T., Gaga M., Sichletidis L., et al. (2009).  Long-term prognosis of asthma is good--a 12-year follow-up study. Influence of treatment.. J Asthma. 46(6), 625-31.
Porpodis, K., Domvri K., Zarogoulidis P., Petridis D., Tsirgogianni K., Papaioannou A., et al. (2015).  Roflumilast, a phosphodiesterase-4 inhibitor, induces phagocytic activity in Greek COPD patients.. Int J Chron Obstruct Pulmon Dis. 10, 1123-8.

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές